SMTL ID : 8vmg.2 (1 other biounit)

Crystal structure of GSK-3 26-383 bound to Axin 383-435

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

hetero-1-1-mer

Ligands

1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

MES.1: 11 residues within 4Å: Chain A: V.45, A.58, K.60, V.85, L.107, D.108, Y.109, V.110, L.163, C.174, D.175 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:V.110, A:D.175 Water bridges: A:F.176 Salt bridges: A:K.60

19 x EDO: 1,2-ETHANEDIOL

EDO.2: 4 residues within 4Å: Chain A: L.128, P.129, V.130, I.131 Ligand excluded by PLIP EDO.3: 2 residues within 4Å: Chain A: K.158, S.194 Ligand excluded by PLIP EDO.4: 5 residues within 4Å: Chain A: G.40, S.41, F.42 Ligands: EDO.9, EDO.11 Ligand excluded by PLIP EDO.5: 2 residues within 4Å: Chain A: K.98, D.99 Ligand excluded by PLIP EDO.6: 3 residues within 4Å: Chain A: R.119, R.123 Ligands: EDO.8 Ligand excluded by PLIP EDO.7: 8 residues within 4Å: Chain A: R.71, R.155, G.177, S.178, V.189, I.192 Ligands: EDO.11, SO4.21 Ligand excluded by PLIP EDO.8: 4 residues within 4Å: Chain A: R.116, R.119, H.120 Ligands: EDO.6 Ligand excluded by PLIP EDO.9: 10 residues within 4Å: Chain A: G.40, S.41, F.42, G.43, V.44, V.45, K.60, K.61, V.62 Ligands: EDO.4 Ligand excluded by PLIP EDO.10: 6 residues within 4Å: Chain A: K.61, G.95, E.96, E.100, Y.102 Ligands: EDO.13 Ligand excluded by PLIP EDO.11: 7 residues within 4Å: Chain A: F.42, V.62, N.70, E.72, G.177 Ligands: EDO.4, EDO.7 Ligand excluded by PLIP EDO.12: 7 residues within 4Å: Chain A: A.118, R.119, S.122, E.224, G.228, Q.229, P.230 Ligand excluded by PLIP EDO.13: 8 residues within 4Å: Chain A: Y.31, T.34, Y.46, I.59, K.61, F.91, N.104 Ligands: EDO.10 Ligand excluded by PLIP EDO.14: 6 residues within 4Å: Chain A: R.71, Q.74, I.75, K.180, Q.181 Ligands: EDO.19 Ligand excluded by PLIP EDO.15: 3 residues within 4Å: Chain A: R.294, E.308 Ligands: EDO.17 Ligand excluded by PLIP EDO.16: 8 residues within 4Å: Chain A: N.188, V.189, S.190, Y.191, T.207 Chain B: S.5, G.6, G.7 Ligand excluded by PLIP EDO.17: 6 residues within 4Å: Chain A: R.294, L.304, E.308, A.311, H.312 Ligands: EDO.15 Ligand excluded by PLIP EDO.18: 4 residues within 4Å: Chain A: D.235, S.236, D.239 Chain B: R.20 Ligand excluded by PLIP EDO.19: 4 residues within 4Å: Chain A: F.68, R.71, K.180 Ligands: EDO.14 Ligand excluded by PLIP EDO.20: 7 residues within 4Å: Chain A: S.236, G.237, V.238 Chain B: W.3, G.4, S.5 Ligands: SO4.22 Ligand excluded by PLIP

2 x SO4: SULFATE ION

SO4.21: 6 residues within 4Å: Chain A: R.71, R.155, K.180, N.188, V.189 Ligands: EDO.7 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:V.189 Salt bridges: A:R.71, A:R.155, A:K.180 SO4.22: 5 residues within 4Å: Chain A: Y.191, R.195, R.198, G.237 Ligands: EDO.20 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Y.191, A:Y.191 Salt bridges: A:R.195, A:R.198

8 x CL: CHLORIDE ION

CL.23: 3 residues within 4Å: Chain A: A.333, L.334, F.335 Ligand excluded by PLIP CL.24: 2 residues within 4Å: Chain A: T.127, R.281 Ligand excluded by PLIP CL.25: 2 residues within 4Å: Chain A: P.282, R.283 Ligand excluded by PLIP CL.26: 2 residues within 4Å: Chain A: D.208, E.258 Ligand excluded by PLIP CL.27: 2 residues within 4Å: Chain A: Q.270 Chain B: Q.25 Ligand excluded by PLIP CL.28: 2 residues within 4Å: Chain A: Y.191, C.193 Ligand excluded by PLIP CL.29: 3 residues within 4Å: Chain A: S.211, S.212, P.306 Ligand excluded by PLIP CL.30: 2 residues within 4Å: Chain A: K.246 Chain B: R.28 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Enos, M.D. et al., Structural and functional effects of phosphopriming and scaffolding in the kinase GSK-3 beta. Sci.Signal. (2024)

Release Date

2024-08-28

Peptides

Glycogen synthase kinase-3 beta: A
Axin-1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

Glycogen synthase kinase-3 beta

Axin-1

Related Entries With Identical Sequence